Min Vedal
Overview
Explore the profile of Min Vedal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linhares Y, Freytes C, Cherry M, Bachier C, Maris M, Hoda D, et al.
Blood Adv
. 2024 Sep;
8(23):6114-6126.
PMID: 39347584
Lisocabtagene maraleucel (liso-cel) is an autologous, CD19-directed, 4-1BB chimeric antigen receptor (CAR) T-cell product approved for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). We present the OUTREACH primary analysis, evaluating the...
2.
Morschhauser F, Dahiya S, Palomba M, Garcia-Sancho A, Reguera Ortega J, Kuruvilla J, et al.
Nat Med
. 2024 Jul;
30(8):2374.
PMID: 38982297
No abstract available.
3.
Morschhauser F, Dahiya S, Palomba M, Garcia-Sancho A, Reguera Ortega J, Kuruvilla J, et al.
Nat Med
. 2024 Jun;
30(8):2199-2207.
PMID: 38830991
An unmet need exists for patients with relapsed/refractory (R/R) follicular lymphoma (FL) and high-risk disease features, such as progression of disease within 24 months (POD24) from first-line immunochemotherapy or disease...